Top Back to top

Survey on the use of DLI after allogeneic after allogeneic stem cell transplantation across EBMT centers

Cellular Therapy & Immunobiology Working Party (CTIWP)
Study type:
Study number:
8420040
Type of Stem Cell Treatment:
Donor Leukocyte Infusion (DLI)
Diseases:
All diseases
Short title:
Survey on DLI across EBMT centers
Primary objective:
 
Key inclusion criteria:
 
Country:
All EBMT member countries
Principal investigator:
 
Reason for processing personal data:
Not applicable to surveys
Categories of personal data collected:
Not applicable to surveys
Recipients who may access the data:
Not applicable to surveys
3rd-party processors of Personal Data on behalf of EBMT/Service provider:
No

Privacy notices

Article 6 lawful basis for processing personal data:
Article 6.1 (a) - Consent (Collection)
Article 9 basis for processing special category data:
Article 9(2) (a) - Consent (Collection)

Data Protection Impact Assessments

Rights available to individuals:
Access
Data portability
Rectification
Objection
Deletion
Is a Data Protection Impact Assessment required?:
Not applicable to surveys
Retention Schedule (if possible):
Not applicable to surveys